MORONCINI, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 4.132
EU - Europa 2.250
AS - Asia 756
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
SA - Sud America 3
Totale 7.240
Nazione #
US - Stati Uniti d'America 4.122
IT - Italia 602
UA - Ucraina 405
SE - Svezia 303
IE - Irlanda 297
CN - Cina 237
SG - Singapore 234
DE - Germania 219
TR - Turchia 160
DK - Danimarca 149
FI - Finlandia 84
KR - Corea 78
GB - Regno Unito 75
FR - Francia 71
CI - Costa d'Avorio 64
MA - Marocco 25
IN - India 24
BE - Belgio 14
CA - Canada 10
IL - Israele 7
PL - Polonia 6
EU - Europa 5
RO - Romania 5
AU - Australia 4
JP - Giappone 4
RS - Serbia 4
MY - Malesia 3
NL - Olanda 3
AL - Albania 2
AT - Austria 2
BR - Brasile 2
CH - Svizzera 2
PK - Pakistan 2
PT - Portogallo 2
RU - Federazione Russa 2
TW - Taiwan 2
YE - Yemen 2
BD - Bangladesh 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
ID - Indonesia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 7.240
Città #
Chandler 621
Jacksonville 426
Fairfield 334
Boardman 292
Dublin 292
Ashburn 266
Des Moines 261
Wilmington 186
Woodbridge 155
Centro 149
Houston 142
New York 142
Seattle 126
Ann Arbor 115
Lawrence 108
Princeton 108
Singapore 98
San Mateo 92
Cambridge 80
Abidjan 64
Ancona 52
Redmond 45
Turin 37
Beijing 36
San Diego 35
Marche 30
Tolentino 30
Shanghai 24
Washington 23
Los Angeles 20
London 19
Guangzhou 18
Jesi 17
Pune 14
Wuhan 14
Dallas 13
Brussels 12
Helsinki 12
Milan 12
Falls Church 11
Jiaxing 11
Kilburn 11
Izmir 8
Jinhua 8
Norwalk 7
Yiwu 7
Macerata 6
Monte San Pietrangeli 6
Shenzhen 6
Southwark 6
Visakhapatnam 6
West Jordan 6
Ascoli Piceno 5
Chiaravalle 5
Falconara Marittima 5
Jerusalem 5
Nürnberg 5
Osimo 5
Ottawa 5
Rome 5
Squinzano 5
Auburn Hills 4
Belgrade 4
Brisbane 4
Bucharest 4
Fermo 4
Genoa 4
Montelupone 4
Nuremberg 4
Scuola 4
Camerino 3
Montréal 3
New Bedfont 3
Pagani 3
Pesaro 3
Petaling Jaya 3
Porto 3
Senigallia 3
Wuxi 3
Amsterdam 2
Bengaluru 2
Brescia 2
Buffalo 2
Caerano di San Marco 2
Chengdu 2
Clifton 2
Dongguan 2
Fabriano 2
Florence 2
Gessate 2
Hanover 2
Heze 2
Hounslow 2
Leawood 2
Lisbon 2
Loreto 2
Montefortino 2
Montelabbate 2
Monza 2
Nanjing 2
Totale 4.769
Nome #
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 125
The first outstanding 50 years of “Università Politecnica delle Marche”: Research achievements in life sciences 124
The value of admission Troponin I to predict outcomes in suspected infections in elderly patients admitted in Internal Medicine: results from the SOFA-T collaboration, a multi-center study 122
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 119
Preface 110
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 109
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 103
Development of the optimal touchscreen interface for patients with scleroderma 103
Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management 102
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 99
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 99
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 96
Hypothalamic-pituitary-adrenal axis disregulation in PrPC-null mice. 94
Adalimumab modulates angiogenesis in psoriatic skin 93
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 90
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 89
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 88
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 87
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 86
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 84
Pathogenic autoantibodies in systemic sclerosis 82
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 82
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 78
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 76
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 76
MOTIF-GRAFTED HYBRID POLYPEPTIDES AND USES THEREOF 75
null 75
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 74
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 74
Analysis of ATP8B4 F436L missense variant in a large systemic sclerosis cohort 74
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 74
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 73
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 73
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 72
Biologics in inflammatory immune-mediated systemic diseases 71
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 71
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance 70
Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin. 70
Delection of typical and atypical bovine spongiform encephalopathy and scraipe prion strains by prion protein motif-grafted antibodies 69
History and scientific production of clinica medica and clinica ematologica in ancona 69
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. 67
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 67
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 67
Agonistic antibodies in systemic sclerosis 67
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin 67
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 67
Detection of typical and atypical BSE and scrapie prion strains by prion protein motif-grafted antibodies. 66
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 66
Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. 65
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 65
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 65
Reactivation of Hepatitis B Virus Infection Associated with Anti-Tumor Necrosis Factor-α Therapy 65
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 64
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 63
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 63
BIOLOGIC THERAPY IN INFLAMMATORY IMMUNOMEDIATED SYSTEMIC DISEASES: SAFETY PROFILE 63
Update of EULAR recommendations for the treatment of systemic sclerosis 62
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 62
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 61
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 61
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways 61
Risk prediction of clinical adverse outcomes with machine learning in a cohort of critically ill patients with atrial fibrillation 61
null 58
Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress 57
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 56
Role of viral infections in the etiopathogenesis of systemic sclerosis 55
Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof 54
Development of A Solid Phase Binding Assay For Detection of Conformational Anti-PDGFR Autoantibodies In the Serum of Patients Affected By Scleroderma 53
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 53
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 52
Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc 52
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 52
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 51
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 51
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 51
Reply 51
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 48
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 47
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 46
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 46
Letter to the Editor. Reply to Magalon J et al. (CT-1406) 46
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 45
New insights into the role of oxidative stress in scleroderma fibrosis. 45
The proinflammatory cytokine interleukin 18 regulates feeding by acting on the bed nucleus of the stria terminalis 44
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. 44
Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody 43
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 42
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 42
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 42
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach 41
Current take on systemic sclerosis patients’ vaccination recommendations 41
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 40
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 39
Restricted immunoglobulin repertoire and evolutionary mechanism of PDGFR-autoreactive memory B cells in systemic sclerosis 39
Monoacylglycerol lipase regulates fever response 39
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 39
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 38
STIMULATORY AUTOANTIBODIES AGAINST PDGF RECEPTOR IN A LARGE COHORT OF ITALIAN SCLERODERMA PATIENTS 38
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 37
Echocardiographic predictors of mortality in intermediate-risk pulmonary embolism 37
Totale 6.669
Categoria #
all - tutte 43.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.960


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020437 0 0 0 0 87 7 95 10 90 7 27 114
2020/20211.469 67 141 176 3 185 98 177 104 162 129 152 75
2021/2022865 44 190 23 29 22 43 20 53 83 57 125 176
2022/20231.821 148 189 128 162 113 403 9 101 382 24 122 40
2023/20241.153 163 38 66 138 167 233 21 51 11 82 57 126
2024/2025745 327 270 75 51 22 0 0 0 0 0 0 0
Totale 7.532